Within this dataset of 33 published records, the ranked leader holds 33 tracked families, a University of Michigan-affiliated filer working with a small group of named inventors on regenerative peripheral nerve interface technology. The next-closest institution in the six-name ranking is a fair distance behind, and the fifth-place assignee holds only 1 family. This is a concentrated field led by academic research groups rather than a broad set of competing manufacturers, so freedom-to-operate work should start with the leader’s family tree before looking elsewhere.

The representative record in this dataset, US9808616B2, claims an RPNI built from an insulating substrate carrying a thin-film metallic electrode array, part of it coated with a conductive polymer and a layer of decellularized small intestinal submucosa (SIS), with a second conductive polymer electrochemically polymerized through the SIS and muscle tissue placed in contact with the assembly. In practice this locks down a specific electrode-coating and tissue-interface construction rather than the general concept of nerve interfacing. Designs that avoid the SIS coating and dual-polymer polymerization step have more room to operate, though they still need to clear the wider family of related filings from the same assignee.

Filing activity was near zero through 2017 and stayed low for several years before jumping to a peak of 28 records in 2024. There are not yet enough complete years after accounting for publication lag to state a reliable growth rate, so any trend line drawn from this data should be treated as provisional. What can be said is that the field’s patent activity is recent and concentrated around a short window rather than built up steadily since 2015.